{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:01:10Z","timestamp":1790758870331,"version":"4.1.0"},"reference-count":59,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,6]]},"DOI":"10.18632\/oncotarget.24892","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T12:17:50Z","timestamp":1523017070000},"page":"18494-18509","source":"Crossref","is-referenced-by-count":38,"title":["Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model"],"prefix":"10.18632","volume":"9","author":[{"given":"Yuuki","family":"Ohara","sequence":"first","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan Hwu","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Misawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Somiya","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Sekido","sequence":"additional","affiliation":[{"name":"Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Lipson","sequence":"additional","affiliation":[{"name":"FibroGen, Inc., San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Toyokuni","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"},{"name":"Sydney Medical School, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"1","volume-title":"Pathology of asbestos-associated diseases","author":"Sporn","year":"2014"},{"key":"2","first-page":"219","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans. a review of human carcinogens; part c: Arsenic, metals, fibres, and dusts","author":"IARC, WHO","year":"2012"},{"key":"3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Lake","year":"2005","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050","volume":"92","author":"Peto","year":"2005","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.sandf.2012.11.008","article-title":"Geo-environmental issues induced by the 2011 off the pacific coast of Tohoku earthquake and tsunami","volume":"52","author":"Katsumi","year":"2012","journal-title":"Soils Found"},{"key":"6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/es025730g","article-title":"Persistent organic pollutants in the dusts that settled across lower Manhattan after September 11, 2001","volume":"37","author":"Lioy","year":"2003","journal-title":"Environ Sci Technol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"van Meerbeeck","year":"2012","journal-title":"J Thorac Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2008.01001.x","article-title":"Role of iron in carcinogenesis: cancer as a ferrotoxic disease","volume":"100","author":"Toyokuni","year":"2009","journal-title":"Cancer Sci"},{"key":"9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cas.13460","article-title":"Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats","volume":"109","author":"Toyokuni","year":"2018","journal-title":"Cancer Sci"},{"key":"10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.4377","article-title":"Connective tissue growth factor and beta-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma","volume":"233","author":"Toyokuni","year":"2014","journal-title":"J Pathol"},{"key":"11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-beta synergizes with defects in the hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Osada","year":"2012","journal-title":"J Exp Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","article-title":"Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases","volume":"28","author":"Gressner","year":"2008","journal-title":"Liver Int"},{"key":"13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/CS20140264","article-title":"Cellular and molecular actions of CCN2\/CTGF and its role under physiological and pathological conditions","volume":"128","author":"Takigawa","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11373-008-9264-9","article-title":"Connective tissue growth factor (CTGF) and cancer progression","volume":"15","author":"Kuo","year":"2008","journal-title":"J Biomed Sci"},{"key":"15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ijc.28972","article-title":"Deregulated expression of connective tissue growth factor (CTGF\/CCN2) is linked to poor outcome in human cancer","volume":"137","author":"Kees","year":"2015","journal-title":"Int J Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","article-title":"Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta","volume":"4","author":"De Robertis","year":"2002","journal-title":"Nat Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1038\/cddis.2014.453","article-title":"CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression","volume":"5","author":"Tang","year":"2014","journal-title":"Cell Death Dis"},{"key":"18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/oxfordjournals.jbchem.a022414","article-title":"Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells","volume":"126","author":"Takigawa","year":"1999","journal-title":"J Biochem"},{"key":"19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bone.2008.08.125","article-title":"CCN family 2\/connective tissue growth factor (CCN2\/CTGF) regulates the expression of VEGF through hif-1alpha expression in a chondrocytic cell line, hcs-2\/8, under hypoxic condition","volume":"44","author":"Takigawa","year":"2009","journal-title":"Bone"},{"key":"20","doi-asserted-by":"crossref","first-page":"55958","DOI":"10.1074\/jbc.M407810200","article-title":"Connective tissue growth factor (CTGF) is regulated by wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells","volume":"279","author":"He","year":"2004","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"L786","DOI":"10.1152\/ajplung.00243.2013","article-title":"Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor","volume":"306","author":"Kim","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"22","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1158\/0008-5472.CAN-06-0081","article-title":"Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis","volume":"66","author":"Longaker","year":"2006","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1158\/1535-7163.MCT-05-0516","article-title":"Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer","volume":"5","author":"Korc","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"24","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1073\/pnas.1300415110","article-title":"CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer","volume":"110","author":"Tuveson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2013.47","article-title":"CTGF is a therapeutic target for metastatic melanoma","volume":"33","author":"Powell","year":"2014","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"publisher","first-page":"44551","DOI":"10.18632\/oncotarget.6082","article-title":"Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer","volume":"6","author":"Hacker","year":"2015","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1183\/13993003.01030-2015","article-title":"FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis","volume":"47","author":"Stauffer","year":"2016","journal-title":"Eur Respir J"},{"key":"28","first-page":"1","article-title":"FG-3019, a human monoclonal antibody to connective tissue growth factor, combined with chemotherapy in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma","volume":"2","author":"Lopez","year":"2017","journal-title":"J Cancer Clin Trials"},{"key":"29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the european respiratory society and the european society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Pairon","year":"2010","journal-title":"Eur Respir J"},{"key":"30","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"J Clin Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Szondy","year":"2004","journal-title":"J Clin Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/JTO.0b013e31817c73ec","article-title":"Single-agent pemetrexed for chemonaive and pretreated patients with malignant pleural mesothelioma: results of an international expanded access program","volume":"3","author":"Adachi","year":"2008","journal-title":"J Thorac Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00280-005-0036-1","article-title":"Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients","volume":"57","author":"Johnson","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.27611","article-title":"SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma","volume":"132","author":"Naka","year":"2013","journal-title":"Int J Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10637-007-9060-9","article-title":"chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression","volume":"25","author":"Niyikiza","year":"2007","journal-title":"Invest New Drugs"},{"key":"36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.18632\/oncotarget.1760","article-title":"Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer","volume":"5","author":"Dennis","year":"2014","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bjc.6605501","article-title":"The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy","volume":"102","author":"Lunec","year":"2010","journal-title":"Br J Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2007.11.155","article-title":"Functional requirement of CCN2 for intramembranous bone formation in embryonic mice","volume":"366","author":"Takigawa","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00277-013-1939-2","article-title":"Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth","volume":"93","author":"Konopleva","year":"2014","journal-title":"Ann Hematol"},{"key":"40","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1172\/JCI43230","article-title":"CTGF directs fibroblast differentiation from human mesenchymal stem\/stromal cells and defines connective tissue healing in a rodent injury model","volume":"120","author":"Mao","year":"2010","journal-title":"J Clin Invest"},{"key":"41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.exphem.2005.07.003","article-title":"Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood","volume":"33","author":"Ho","year":"2005","journal-title":"Exp Hematol"},{"key":"42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.humpath.2006.12.013","article-title":"Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma","volume":"38","author":"Davidson","year":"2007","journal-title":"Hum Pathol"},{"key":"43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/path.2120","article-title":"Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma","volume":"211","author":"Bueno","year":"2007","journal-title":"J Pathol"},{"key":"44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3892\/ijo.2012.1715","article-title":"Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: role of inhibitor of apoptosis proteins (IAPs) and caspases","volume":"42","author":"Fox","year":"2013","journal-title":"Int J Oncol"},{"key":"45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00280-007-0500-1","article-title":"Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma","volume":"61","author":"Bueno","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"47","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4161\/cc.5.15.3112","article-title":"Stromal fibroblasts in cancer: a novel tumor-promoting cell type","volume":"5","author":"Weinberg","year":"2006","journal-title":"Cell Cycle"},{"key":"48","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1158\/1078-0432.CCR-15-2010","article-title":"Phase ib study of PEGylated recombinant human hyaluronidase and gemcitabine in patients with advanced pancreatic cancer","volume":"22","author":"Jiang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20150542","article-title":"IKKbeta in intestinal mesenchymal cells promotes initiation of colitis-associated cancer","volume":"212","author":"Kollias","year":"2015","journal-title":"J Exp Med"},{"key":"50","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1084\/jem.20150576","article-title":"IKKbeta acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis","volume":"212","author":"Greten","year":"2015","journal-title":"J Exp Med"},{"key":"51","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2215\/CJN.09321209","article-title":"Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria","volume":"5","author":"Sewell","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"52","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1158\/0008-5472.CAN-08-2524","article-title":"Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of BCL-Xl and CIAP1","volume":"69","author":"Kuo","year":"2009","journal-title":"Cancer Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-016-0511-9","article-title":"Inhibition of BMP and of TGFbeta receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death","volume":"15","author":"Langenfeld","year":"2016","journal-title":"Mol Cancer"},{"key":"54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Hida","year":"2006","journal-title":"Cancer Sci"},{"key":"55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/onc.2013.528","article-title":"Lim-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via hippo signaling cascade","volume":"34","author":"Sekido","year":"2015","journal-title":"Oncogene"},{"key":"56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.freeradbiomed.2017.02.011","article-title":"Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma","volume":"106","author":"Toyokuni","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"57","doi-asserted-by":"publisher","first-page":"69565","DOI":"10.18632\/oncotarget.11829","article-title":"Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma","volume":"7","author":"Toyokuni","year":"2016","journal-title":"Oncotarget"},{"key":"58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/carcin\/bgt267","article-title":"Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production","volume":"35","author":"Toyokuni","year":"2014","journal-title":"Carcinogenesis"},{"key":"59","first-page":"291","article-title":"Quantification of histochemical staining by color deconvolution","volume":"23","author":"Johnston","year":"2001","journal-title":"Anal Quant Cytol Histol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:13:39Z","timestamp":1589040819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":59,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2018,4,6]]}},"alternative-id":["24892","29719620"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24892","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]}}}